EGFR monoclonal antibody (standard-of-care)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR monoclonal antibody (standard-of-care), covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer [Phase 2]